A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany
Authors
Keywords
-
Journal
EPILEPSIA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-28
DOI
10.1111/epi.16099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quality of life and correlating factors in children, adolescents with epilepsy, and their caregivers: A cross-sectional multicenter study from Germany
- (2019) Janna Riechmann et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany
- (2019) Adam Strzelczyk et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- General Trends in Prices and Prescription Patterns of Anticonvulsants in Germany between 2000 and 2017: Analysis of National and Cohort-Based Data
- (2019) Laurent M. Willems et al. Applied Health Economics and Health Policy
- The direct and indirect costs of Dravet Syndrome
- (2018) Melanie D. Whittington et al. EPILEPSY & BEHAVIOR
- Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 — A ten-year overview
- (2018) Laurent M. Willems et al. EPILEPSY & BEHAVIOR
- Incidence, Risk Factors and Consequences of Epilepsy-Related Injuries and Accidents: A Retrospective, Single Center Study
- (2018) Laurent M. Willems et al. Frontiers in Neurology
- Caregiver impact and health service use in high and low severity Dravet syndrome: A multinational cohort study
- (2018) Lieven Lagae et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology
- (2017) Robert S. Fisher et al. EPILEPSIA
- ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
- (2017) Ingrid E. Scheffer et al. EPILEPSIA
- Dravet syndrome: Characteristics, comorbidities, and caregiver concerns
- (2017) Nicole Villas et al. EPILEPSY & BEHAVIOR
- From genotype to phenotype in Dravet disease
- (2017) Svetlana Gataullina et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Mortality in Dravet syndrome
- (2016) Monica S. Cooper et al. EPILEPSY RESEARCH
- The incidence ofSCN1A-related Dravet syndrome in Denmark is 1:22,000: A population-based study from 2004 to 2009
- (2015) Allan Bayat et al. EPILEPSIA
- Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany
- (2015) Janna Riechmann et al. EPILEPSIA
- Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam
- (2014) Adam Strzelczyk et al. EPILEPSY & BEHAVIOR
- Health-related quality of life and depression in Rett syndrome caregivers
- (2013) Adrijan Sarajlija et al. Vojnosanitetski Pregled
- Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
- (2012) A. Brunklaus et al. BRAIN
- Evaluation of health-care utilization among adult patients with epilepsy in Germany
- (2012) Adam Strzelczyk et al. EPILEPSY & BEHAVIOR
- The core Dravet syndrome phenotype
- (2011) Charlotte Dravet EPILEPSIA
- Comorbidities and predictors of health-related quality of life in Dravet syndrome
- (2011) Andreas Brunklaus et al. EPILEPSIA
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
- (2009) Patrick Kwan et al. EPILEPSIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started